Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial. Hill AM, Elbirt D. AIDS 2024;38:1430-1431.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hill AM, Elbirt D. Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial. AIDS 2024;38:1430-1431.
PMID: 38932745